NON-QUALIFIED STOCK OPTION AGREEMENT FOR CONSULTANTS UNDER BLUEPRINT MEDICINES CORPORATIONNon-Qualified Stock Option Agreement • August 1st, 2018 • Blueprint Medicines Corp • Pharmaceutical preparations
Pursuant to the Blueprint Medicines Corporation 2015 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Blueprint Medicines Corporation (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
RESTRICTED STOCK UNIT AWARD AGREEMENT FOR CONSULTANTS UNDER BLUEPRINT MEDICINES CORPORATIONRestricted Stock Unit Award Agreement • August 1st, 2018 • Blueprint Medicines Corp • Pharmaceutical preparations
Pursuant to the Blueprint Medicines Corporation 2015 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Blueprint Medicines Corporation (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.001 per share (the “Stock”) of the Company.
LICENSE AND COLLABORATION AGREEMENT by and between Blueprint Medicines Corporation and CStone Pharmaceuticals Dated as of June 1, 2018License and Collaboration Agreement • August 1st, 2018 • Blueprint Medicines Corp • Pharmaceutical preparations • New York
This LICENSE AND COLLABORATION AGREEMENT (this “Agreement”) is made as of June 1, 2018 (the “Effective Date”) by and between Blueprint Medicines Corporation, a Delaware corporation (“Blueprint”), having a place of business at 45 Sidney Street, Cambridge MA 02139, USA, and CStone Pharmaceuticals, a corporation organized under the laws of the Cayman Islands (“CStone”), having a place of business at Vistra (Cayman) Limited, Floor 4, Willow House, Cricket Square, PO Box 2804, Grand Cayman KY1-1112, Cayman Islands. Blueprint and CStone are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
RESTRICTED STOCK UNIT AWARD AGREEMENT FOR COMPANY EMPLOYEES UNDER BLUEPRINT MEDICINES CORPORATIONRestricted Stock Unit Award Agreement • August 1st, 2018 • Blueprint Medicines Corp • Pharmaceutical preparations
Pursuant to the Blueprint Medicines Corporation 2015 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Blueprint Medicines Corporation (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.001 per share (the “Stock”) of the Company.
NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEES UNDER BLUEPRINT MEDICINES CORPORATIONNon-Qualified Stock Option Agreement • August 1st, 2018 • Blueprint Medicines Corp • Pharmaceutical preparations
Pursuant to the Blueprint Medicines Corporation 2015 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Blueprint Medicines Corporation (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
RESTRICTED STOCK UNIT AWARD AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER BLUEPRINT MEDICINES CORPORATIONRestricted Stock Unit Award Agreement • August 1st, 2018 • Blueprint Medicines Corp • Pharmaceutical preparations
Pursuant to the Blueprint Medicines Corporation 2015 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Blueprint Medicines Corporation (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.001 per share (the “Stock”) of the Company.
